Meldonium Inhibits Cell Motility and Wound-Healing in Trabecular Meshwork Cells and Scleral Fibroblasts: Possible Applications in Glaucoma
Meldonium (MID) is a synthetic drug designed to decrease the availability of L-carnitine-a main player in mitochondrial energy generation-thus modulating the cell pathways of energy metabolism. Its clinical effects are mostly evident in blood vessels during ischemic events, when the hyperproduction...
Saved in:
Main Authors: | Cristina Minnelli (Author), Francesco Piva (Author), Monia Cecati (Author), Tatiana Armeni (Author), Giovanna Mobbili (Author), Roberta Galeazzi (Author), Alberto Melecchi (Author), Martina Cristaldi (Author), Roberta Corsaro (Author), Dario Rusciano (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2023-04-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Protective Effects of Rapamycin on Trabecular Meshwork Cells in Glucocorticoid-Induced Glaucoma Mice
by: Xiaolu Zhu, et al.
Published: (2020) -
Non-Viral Gene Therapy in Trabecular Meshwork Cells to Prevent Fibrosis in Minimally Invasive Glaucoma Surgery
by: Jinyuan Luo, et al.
Published: (2022) -
Characterization of TGF-β by Induced Oxidative Stress in Human Trabecular Meshwork Cells
by: Hsin-Yi Chen, et al.
Published: (2021) -
Rho-Associated Protein Kinase Inhibitor Treatment Promotes Proliferation and Phagocytosis in Trabecular Meshwork Cells
by: Wenshi Chen, et al.
Published: (2020) -
Synthesis, Characterization and Antioxidant Properties of a New Lipophilic Derivative of Edaravone
by: Cristina Minnelli, et al.
Published: (2019)